Page 3 - Japanese (NIKKEI) Growth Pharmaceuticals & Biotech Stocks

UPDATED Aug 16, 2025

Discover Japanese Pharmaceuticals & Biotech Growth Stocks that are on the NIKKEI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

89 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
7079
WDB coco
JP¥2,680.00-13.0%-33.4%JP¥6.4bn/aPE7.7xn/a3.0%
2370
MEDINET
JP¥38.000%-15.6%JP¥10.1bn/an/an/an/a
4570
Immuno-Biological Laboratories
JP¥486.00-4.3%4.1%JP¥4.5bn/aPE17.5xn/a1.2%
4598
Delta-Fly Pharma
JP¥642.00-5.0%12.2%JP¥6.2bn/aPB9.6xn/an/a
4892
Cyfuse Biomedical K.K
JP¥667.001.7%2.8%JP¥5.5bn/aPS85.2xn/an/a
4596
Kubota Pharmaceutical Holdings
JP¥51.004.1%-28.2%JP¥3.0bn/aPS99.3xn/an/a
4534
Mochida Pharmaceutical
JP¥3,135.00-2.8%-4.7%JP¥111.1bn/aPE18.4xn/a2.6%
311A
NPTLtd
JP¥1,200.000%n/aJP¥5.8bn/an/an/an/a
4888
Stella Pharma
JP¥407.00-1.0%-2.4%JP¥13.9bn/aPS14xn/an/a
4894
Cuorips
JP¥6,800.0012.4%3.0%JP¥55.1bn/aPS211.8xn/an/a
4576
D. Western Therapeutics Institute
JP¥117.004.5%41.0%JP¥5.3bn/aPS12.6xn/an/a
4597
Solasia Pharma K.K
JP¥38.00-2.6%-35.6%JP¥9.2bn/aPS31.3xn/an/a
4582
SymBio Pharmaceuticals
JP¥154.00-1.3%-35.8%JP¥7.5bn/aPS4.1xn/an/a
2183
Linical
JP¥341.000.9%-9.1%JP¥7.7bn/aPB1.2xn/a4.7%
4575
CanBas
JP¥1,055.002.9%64.6%JP¥20.2bn/aPB6.9xn/an/a
6090
Human Metabolome Technologies
JP¥737.00-5.4%26.4%JP¥4.3bn/aPE16.7xn/a2.0%
4884
Kringle Pharma
JP¥497.000.8%-45.8%JP¥3.4bn/aPS46.9xn/an/a
4591
Ribomic
JP¥105.00-11.8%11.7%JP¥4.7bn/aPS4682xn/an/a
4891
TMS
JP¥162.001.9%-22.5%JP¥7.3bJP¥760.00PB2.4xn/an/a
4579
RaQualia Pharma
JP¥560.00-11.3%-5.2%JP¥13.7bn/aPS4.2xn/an/a
4538
Fuso Pharmaceutical IndustriesLtd
JP¥2,176.00-4.4%-4.1%JP¥18.6bn/aPE7.1xn/a4.1%
8095
Astena Holdings
JP¥513.00-0.6%1.8%JP¥20.7bn/aPB0.8xn/a3.5%
4512
Wakamoto PharmaceuticalLtd
JP¥314.002.6%29.2%JP¥10.9bn/an/an/a1.0%
4539
Nippon Chemiphar
JP¥1,600.001.1%0.3%JP¥5.8bn/aPE14.6xn/a3.1%
Page 3 of 4